Cell & Gene Therapies

— When precision is paramount

When transporting cell & gene therapies, precision is non-negotiable and there are no second chances.

Exposure to incorrect temperatures, even for short periods, can compromise the potency, safety, and viability of these treatments, leading to significant financial losses and, more importantly, potential harm to patients. From -150°C to -70°C, we ensure consistent temperature control, mitigating the risks associated with temperature excursions and addressing the specialized needs of cell & gene therapy (CGT) transportation with unparalleled precision.

Explore Solution

CryoSure® LN2 — Formerly va-Q-genic

Payload: 0.2 L – 10.5 L
Temperature: < -150°C
Autonomy: 9 – 35 days

Explore Solution

ProofPak — Formerly va-Q-proof

Payload: 5 L – 264 L
Temperature: -70 °C to +37 °C
Autonomy: 96 - 144 h

Key Benefits

We ensure that life-changing treatments reach patients in optimal condition, safeguarding the future of cell and gene therapies and transforming patient lives.

Real-time monitoring

Safeguard the efficacy of your products with real-time Live Monitoring, providing instant visibility into shipment conditions throughout its journey. You can proactively intervene to prevent temperature excursions if the unexpected happens, minimizing product loss and ensuring product efficacy upon arrival.

Precise control

Drawing on 40 years of expertise, our tailored solutions for temperature-sensitive pharmaceuticals enable precise temperature control, from -150°C to +37°C. Rigorously tested against extreme conditions, we ensure product protection throughout its journey, preserving efficacy and stability.

Unbeatable durations

Our CGT solutions offer superior duration of up to 3 weeks. This ensures extended product stability, reducing the risk of product spoilage and ensuring the efficacy of your temperature-sensitive cell & gene therapies upon arrival.

Industry Insights

Cold chain logistics: 3 myths emerging biopharma must overcome

For emerging biopharma, managing cold chain logistics can feel like navigating a maze. With complex regulatory requirements, strict temperature controls and high stakes for product integrity, the logistics of getting temperature-sensitive therapies to market can seem daunting.
Learn more

Understanding the Complexities of Shipping Rare Disease and Orphan Drugs

Rare and orphan diseases affect a relatively small number of individuals within the global population (less than 200,000 people in the US or less than 5 in 10,000 people in Europe). Due to the high costs associated with research and development and a limited patient pool, companies developing such products often incur a financial loss, and so the pharmaceutical industry has been forced to neglect many rare diseases.
Learn more